HemaCare Corporation operates in the Health and allied services sector. HemaCare Corporation (HemaCare) provides the customized delivery of blood products and services. The Company collects, processes and distributes blood products to hospitals and research related organizations. The Company operates and manages donor centers and mobile donor vehicles to collect transfusable blood products from donors. In addition, the Company provides blood related services, therapeutic apheresis procedures, stem cell collection and other blood treatments to patients with a variety of disorders. Blood related therapeutic services are usually provided to hospitals under contract as an outside purchased service. HemaCare operates in two business segments: blood services segment and therapeutic segment. The blood services segment supplies customers with red blood cells, apheresis platelets and other blood products. The therapeutic segment includes therapeutic apheresis procedures, stem cell collection and other blood therapies provided to patients in a hospital setting. In our complete report available for purchase the company is compared to: Conmed Healthcare Management Inc, Cryo-Cell International, Inc. and Advanced Medical Institute Inc..